U.S. Medical Equipment Stock News

PJT Partners (PJT) has drawn fresh attention after reporting higher second quarter and year to date earnings, along with continued share repurchases and a declared quarterly dividend of $0.25 per Class A share. See our latest analysis for PJT Partners. At a share price of $171.34, PJT Partners has seen a 30 day share price return of 9.19% and a 90 day share price return of 11.74%, while the 1 year total shareholder return has declined 2.35%. Recent interest appears linked to stronger...

Why SPX Technologies Earnings Matter For Investors Now SPX Technologies (SPXC) is in focus after second quarter 2026 results showed higher sales of US$679 million and net income of US$78.4 million compared with the prior year, along with increased full year revenue guidance. See our latest analysis for SPX Technologies. SPX Technologies shares trade at US$215.68 after a 6.1% year to date share price return and a 7% one year total shareholder return. The three year total shareholder return of...

Halliburton (HAL) is drawing fresh attention after partnering with nuclear waste startup Deep Isolation to apply its drilling expertise to radioactive waste disposal. The move introduces a new environmental angle that some investors will scrutinize. See our latest analysis for Halliburton. Halliburton’s recent nuclear waste partnership comes as the stock trades at US$31.89, with the share price falling 7.27% over the past month and 23.53% over the past quarter, yet showing a 7.74% year to...

Spire Inc. has reported its third-quarter and nine-month results to June 30, 2026, showing higher sales and net income, while also completing the divestitures of Spire Marketing and Spire Storage and continuing its long history of regular dividends, including a US$0.825 per share payout declared for October 2, 2026. Beyond the headline growth in earnings, the combination of divestitures, reaffirmed multi-year EPS guidance, and a 23-year streak of annual dividend increases highlights Spire's...

Laureate Education (LAUR) had a busy July 30, 2026, reporting raised full year revenue guidance, solid second quarter results, and a larger share buyback authorization that adds a fresh angle for investors. See our latest analysis for Laureate Education. Over the past year, Laureate Education has combined a 15.1% year to date share price return with a 1 year total shareholder return of 49.65%. The recent 30 day share price pullback of 5.24% comes after a 16.96% 90 day gain, which suggests...

NGL Energy Partners LP recently reported first-quarter 2026 results, with revenue rising to US$989.99 million from US$622.16 million and net income increasing to US$78.73 million from US$68.92 million a year earlier, alongside a swing from a basic loss per share from continuing operations of US$0.26 to earnings of US$0.48. This shift from a prior loss to positive earnings per share from continuing operations highlights a meaningful improvement in profitability and operating performance for...

In late July 2026, Quaker Chemical reported stronger second-quarter results with higher sales and a return to profitability, raised its quarterly dividend to US$0.53 per share, refreshed its capital structure, filed shelf registrations for common shares, and confirmed it is actively pursuing acquisitions to support long-term growth. The combination of improved earnings, a higher cash dividend, a new share repurchase authorization, and management’s emphasis on disciplined M&A highlights a...

Host Hotels & Resorts targets acquisitions after updated 2026 outlook Host Hotels & Resorts (HST) has put potential acquisitions on the agenda after raising its full year 2026 earnings guidance, giving investors fresh information on both its capital plans and profit expectations. See our latest analysis for Host Hotels & Resorts. Host Hotels & Resorts shares trade at $23.29, with the 1-year total shareholder return of 64.64% and 5-year total shareholder return of 89.91% pointing to strong...

In early August 2026, Vestis workers in Indianapolis represented by Teamsters Local 135 ended a 19-day strike by ratifying a three-year agreement that delivers wage increases, a guaranteed 40-hour work week, and Teamsters health care through the Michigan Conference of Teamsters Health and Welfare Fund. Beyond resolving the immediate work stoppage, the deal highlights a reset in labor relations at a time when Vestis is already emphasizing operational discipline and route efficiency across its...

With global food costs climbing again, as seen in the latest rise in the FAO Food Price Index, investors are watching how pricing power and leadership quality interact. Founder led companies often live or die by the decisions of a single, deeply invested leader. That makes this a compelling moment to focus on founders who are building legacies. This article highlights three standout stocks from the Founder Led Companies screener. The stocks covered below are just a small sample, and the full...

Earlier this week, Argus cut its rating on Century Communities Inc. (CCS), a U.S. homebuilder focused on single-family attached and detached homes, to SELL without citing new operational developments. The absence of fresh business updates around the downgrade highlights how changes in analyst opinions alone can meaningfully sway market expectations for Century Communities. We’ll now examine how Argus’s SELL downgrade may reshape Century Communities’ investment narrative, particularly around...

Freenome (FRNM) stock is in focus after the company and Abbott received U.S. Food and Drug Administration approval for SimpleScreen CRC, a blood based colorectal cancer screening test for average risk adults. See our latest analysis for Freenome. The FDA approval and upcoming U.S. launch of SimpleScreen CRC comes as Freenome trades at US$11.15, with a 30 day share price return of 3.24% and a year to date share price decline of 14.23%. The 1 year total shareholder return is 5.49%, suggesting...

Fears about weakened US democratic guardrails and politicised security decisions are putting the spotlight on defense and security stocks in a new way. Political instability can unsettle markets, yet it can also redirect government attention and budgets. This article looks at how that tension links to real companies. You will see three stocks from our Defense and Security Sector Stocks screener that appear particularly exposed to the current news cycle. The three stocks covered next are just...

Blackstone Mortgage Trust (BXMT) is back in focus after reporting second quarter 2026 results that showed higher reported sales alongside a net loss, reversing the profit recorded in the same period last year. See our latest analysis for Blackstone Mortgage Trust. The latest earnings release and the recent completion of a multi year repurchase program have come against a weak share price backdrop for Blackstone Mortgage Trust. The share price is down 27.36% year to date and the 1 year total...

Protagonist Therapeutics (PTGX) has drawn fresh attention after reporting second quarter 2026 results that shifted from a net loss to net income of US$162.85 million, with earnings emerging from continuing operations. See our latest analysis for Protagonist Therapeutics. The sharp move from losses to net income has coincided with strong share price momentum for Protagonist Therapeutics, with a 90 day share price return of 40.94% and a year to date share price return of 67.32%. Over a longer...

Kemper earnings shock and goodwill impairment set the tone Kemper (KMPR) just posted a second quarter net loss of $464.8 million, driven largely by a $460 million non cash goodwill impairment in its specialty auto segment, along with a shift toward tighter, profitability-focused underwriting. See our latest analysis for Kemper. The latest earnings and goodwill impairment news has coincided with a weaker share price backdrop for Kemper, with the stock at US$28.51 and the year to date share...

Why Axogen Stock Is Back in Focus After Q2 Earnings Axogen (AXGN) is back on investor watchlists after its second quarter 2026 earnings report, which combined higher sales with a net loss, along with raised full year revenue guidance and expectations for continued positive free cash flow. See our latest analysis for Axogen. The strong second quarter update, raised 2026 revenue guidance and expectation for continued positive free cash flow help explain why Axogen's share price return is up...

In the past quarter, Omnicell, Inc. reported second-quarter 2026 revenue of US$312.21 million and net income of US$24.29 million, alongside upgraded guidance calling for third-quarter revenue of US$301 million–US$307 million and full-year 2026 revenue of US$1.23 billion–US$1.25 billion. The sharp improvement in profitability versus a year earlier, with net income rising from US$5.64 million to US$24.29 million, highlights how operating efficiency and business mix are influencing Omnicell’s...

BorgWarner Inc. recently reported past second-quarter 2026 results showing slightly higher sales of US$3,648 million and stronger profitability, alongside raising full-year guidance, extending its share repurchase authorization to US$1.35 billion through 2029, and affirming a quarterly dividend of US$0.17 per share. At the same time, BorgWarner has secured multiple new combustion, hybrid, and electrified propulsion program awards across Europe and China, which may enhance its mix of...

Stride (LRN) drew fresh attention after reporting fourth quarter and full year 2026 results, which showed higher net income and earnings per share, along with updated guidance and a change in chief executive leadership. See our latest analysis for Stride. Stride's recent earnings, leadership change and ongoing share repurchase program have come as the share price has risen 27.7% year to date. However, with the 1 year total shareholder return down 44.8%, longer term investors are still relying...

Rapport Therapeutics, Inc. reported second-quarter 2026 results showing a net loss of US$56.62 million, up from US$26.73 million a year earlier, and a basic loss per share from continuing operations of US$1.19 versus US$0.75. For the first half of 2026, the company’s net loss widened to US$76.47 million, with basic loss per share from continuing operations rising to US$1.61 from US$1.44, highlighting a faster increase in aggregate losses than in per-share terms. We will now consider how this...

In late July 2026, CCC Intelligent Solutions Holdings reported second-quarter 2026 results showing sales of US$285.93 million and net income of US$20.79 million, alongside stronger six-month profitability compared with the prior year. On the same date, management issued revenue guidance of US$289.5–US$291.5 million for the third quarter and US$1.16 billion for 2026, highlighting confidence in the scale of its insurance-focused SaaS platform after completing a US$399.99 million buyback...

ZoomInfo Technologies recently reported second-quarter 2026 results, including US$310.4 million in sales, a US$643.7 million net loss driven by a US$650.5 million goodwill impairment, and raised its full-year 2026 revenue guidance to US$1.21 billion–US$1.22 billion. A new partnership with DemandScience and fresh AI-powered customer case studies highlight ZoomInfo’s push to embed its data and workflows deeper into clients’ go-to-market systems, even as it faces a shareholder class action over...

SPS Commerce (SPSC) drew investor attention after its latest quarterly update, which combined higher sales with lower earnings, fresh guidance for 2026, and confirmation of progress on a multi quarter share repurchase program. See our latest analysis for SPS Commerce. The latest earnings update and 2026 guidance appear to have shifted attention back to SPS Commerce’s earnings power and capital returns. The 30 day share price return of 20.59% and 90 day share price return of 39.03% stand in...